Philip Bender1, Walter B Bürgin2, Anton Sculean1, Sigrun Eick3. 1. Department of Periodontology, School of Dental Medicine, University of Bern, Freiburgstrasse 7, -3010, Bern, CH, Switzerland. 2. Ressort Research, University of Bern, School of Dental Medicine, Bern, Switzerland. 3. Department of Periodontology, School of Dental Medicine, University of Bern, Freiburgstrasse 7, -3010, Bern, CH, Switzerland. sigrun.eick@zmk.unibe.ch.
Abstract
OBJECTIVES: Since the peptidyl arginine deiminase of Porphyromonas gingivalis is able to citrullinate peptides and proteins, various studies have suggested the species as a possible link between periodontal disease (PD) and rheumatoid arthritis (RA). This systematic review including meta-analysis was aimed to evaluate whether differences in terms of antibody titers against P. gingivalis exist between RA patients and systemically healthy individuals with and without PD. MATERIALS AND METHODS: The following focused question was addressed: Are the antibody titers against P. gingivalis of RA patients different from systemically healthy individuals with and without PD? A systematic data search was conducted in MEDLINE and EMBASE. The collected data underwent a meta-analysis to detect statistically significant differences in terms of antibody levels between the groups. RESULTS: From 114 articles found by the search 13 articles met the inclusion criteria and provided data suitable for meta-analysis. After analyzing various levels of confinement the meta-analysis revealed a statistically significant higher antibody titer against P. gingivalis in patients suffering from RA in comparison with systemically and periodontally healthy controls (p < 0.01) and systemically healthy patients with PD (p < 0.01). CONCLUSION: The present findings indicate that RA is often accompanied by the presence of an immune response against P. gingivalis. CLINICAL RELEVANCE: The significantly higher antibody response to P. gingivalis in comparison to systemically healthy individuals supports the link between PD and RA by P. gingivalis. Screening of the regularly taken blood samples of RA patients for P. gingivalis antibodies may help to sensitize rheumatologists and RA patients for improving periodontal health.
OBJECTIVES: Since the peptidyl arginine deiminase of Porphyromonas gingivalis is able to citrullinate peptides and proteins, various studies have suggested the species as a possible link between periodontal disease (PD) and rheumatoid arthritis (RA). This systematic review including meta-analysis was aimed to evaluate whether differences in terms of antibody titers against P. gingivalis exist between RApatients and systemically healthy individuals with and without PD. MATERIALS AND METHODS: The following focused question was addressed: Are the antibody titers against P. gingivalis of RApatients different from systemically healthy individuals with and without PD? A systematic data search was conducted in MEDLINE and EMBASE. The collected data underwent a meta-analysis to detect statistically significant differences in terms of antibody levels between the groups. RESULTS: From 114 articles found by the search 13 articles met the inclusion criteria and provided data suitable for meta-analysis. After analyzing various levels of confinement the meta-analysis revealed a statistically significant higher antibody titer against P. gingivalis in patients suffering from RA in comparison with systemically and periodontally healthy controls (p < 0.01) and systemically healthy patients with PD (p < 0.01). CONCLUSION: The present findings indicate that RA is often accompanied by the presence of an immune response against P. gingivalis. CLINICAL RELEVANCE: The significantly higher antibody response to P. gingivalis in comparison to systemically healthy individuals supports the link between PD and RA by P. gingivalis. Screening of the regularly taken blood samples of RApatients for P. gingivalis antibodies may help to sensitize rheumatologists and RApatients for improving periodontal health.
Authors: Cynthia Savioli; Ana Cristina M Ribeiro; Gisele Maria Campos Fabri; Ana Luisa Calich; Jozélio Carvalho; Clovis A Silva; Vilma S T Viana; Eloísa Bonfá; José Tadeu T Siqueira Journal: J Clin Rheumatol Date: 2012-06 Impact factor: 3.517
Authors: David F Lappin; Danae Apatzidou; Anne-Marie Quirke; Jessica Oliver-Bell; John P Butcher; Denis F Kinane; Marcello P Riggio; Patrick Venables; Iain B McInnes; Shauna Culshaw Journal: J Clin Periodontol Date: 2013-08-01 Impact factor: 8.728
Authors: Natalia Wegner; Karin Lundberg; Andrew Kinloch; Benjamin Fisher; Vivianne Malmström; Marc Feldmann; Patrick J Venables Journal: Immunol Rev Date: 2010-01 Impact factor: 12.988
Authors: Gaetano Isola; Ray C Williams; Alberto Lo Gullo; Luca Ramaglia; Marco Matarese; Vincenzo Iorio-Siciliano; Claudio Cosio; Giovanni Matarese Journal: Clin Rheumatol Date: 2017-10-07 Impact factor: 2.980
Authors: William Buwembo; Ian Guyton Munabi; Mark Kaddumukasa; Haruna Kiryowa; Ethel Nankya; William Evan Johnson; Emmy Okello; Nelson Sewankambo Journal: Open J Stomatol Date: 2019-10-10
Authors: Samina A Turk; Dirkjan van Schaardenburg; Maarten Boers; Sylvia de Boer; Cindy Fokker; Willem F Lems; Michael T Nurmohamed Journal: PLoS One Date: 2018-03-22 Impact factor: 3.240